🚀 Pharmidex In Silico Drug Discovery – The Complete Pipeline! 🧬💻
February 28, 2025

At Pharmidex, we bring cutting-edge computational, structural, and molecular biology expertise to accelerate drug discovery and development. Whether you know your protein target and need to find a drug or have drug candidates and need to identify their target, our comprehensive in silico pipeline ensures success.

✨ Why Choose Pharmidex?
✅ Gold-standard software for precision modeling
✅ Hit and binding site identification for target validation
✅ Library mining, extraction, and de novo design
✅ 2D & 3D ligand-based modeling for enhanced screening
✅ Pathway exploration and molecular dynamics analysis
✅ X-ray crystallography & Cryo-EM structure refinement

From target determination to lead optimization, we streamline your drug discovery journey with advanced AI-driven solutions and deep scientific expertise.

📽️ Watch our latest video (5/5) showcasing how Pharmidex transforms drug discovery through computational innovation!

📩 Let’s collaborate and push the boundaries of pharmaceutical innovation together!


#DrugDiscovery #Pharmidex #AIinBiotech #MolecularModeling #PharmaceuticalInnovation

Congratulate Ash Alavijeh as Chief Operating Officer

May 7, 2026
We are delighted to announce and congratulate Ash Alavijeh on his appointment as Chief Operating Officer at Pharmidex . Ash has been an integral part of Pharmidex’s journey, bringing strong leadership, strategic vision and a deep commitment to advancing our capabilities in drug discovery and development. In his new role as COO, he will play a key part in driving operational excellence and supporting the continued growth of the company. This appointment reflects both Ash’s contributions to date and our confidence in his leadership as we continue to expand and evolve. Please join us in congratulating Ash on this well-deserved achievement.

World Asthma Day 🌍

May 5, 2026
Asthma affects over 260 million people worldwide and remains a significant unmet medical need. At Pharmidex , we are proud to support the development of next-generation respiratory therapies through: In vivo respiratory disease models Whole Body Plethysmography (WBP) for functional readouts Integrated PK/PD and bioanalysis Our focus is simple: generate high-quality data that enables confident decision-making and accelerates progress for patients. Because behind every dataset is a patient waiting to breathe easier.

Funding Opportunity for Early-Stage Innovators in Scotland

May 1, 2026
Early-stage innovators based in Scotland have access to a significant opportunity to advance their programs toward ProofOfConcept, with an additional £2.85M fund from the Scottish Government aimed at supporting early development and enabling further investment. 🗓️ Deadline: 8th May At Pharmidex , we work alongside our partners to generate robust, translational data that supports confident decision-making across early discovery and preclinical development. Our capabilities include: TargetExpression ModeOfActionStudies TargetEngagement HitIdentification ADME and PK profiling If you are preparing an application and require scientific input or timely quotations, we would be pleased to support your programme. 🔗 https://lnkd.in/eZ6vVjgN
More Posts